FDA Draws Up Blueprint for Pre-Approval Facility Reviews

Drug GMP Report
A A
The FDA has outlined plans for coordination between CDER and ORA in checking out the manufacturing facilities of drugmakers seeking approval for new pharmaceuticals.

To View This Article:

Login

Subscribe To Drug GMP Report